Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.00    0.00 (0.00%)
Bid:
27.00
Ask:
29.00
Spread: 2.00 (7.407%)
Market Cap: £73.24m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Statement re NAV, Dividend and Offer

27 Jan 2014 17:00

RNS Number : 6223Y
Maven Income and Growth VCT 5 PLC
27 January 2014
 



Maven Income and Growth VCT 5 PLC

 

Net Asset Value, Proposed Final Dividend and Offer for Subscription

 

The Directors of Maven Income and Growth VCT 5 PLC confirm that the unaudited net asset value of the Company as at 30 November 2013 was 37.09p per Ordinary Share.

 

The Directors are recommending the payment of a final dividend of 1.35p per Ordinary Share in respect of the year ended 30 November 2013, to be paid on 30 May 2014 to Shareholders on the register at close of business on 9 May 2014. Subject to the approval of Shareholders at the Annual General Meeting, the proposed final dividend will result in an aggregate payment of 2.00p per share in respect of the year ended 30 November 2013, which represents an increase of 21.21% over the total payment for the prior year.

 

Furthermore, the Directors confirm an unaudited net asset value of the Company as at 21 January 2014 of 40.63p per Ordinary Share, representing an increase of 9.54% over the net asset value as at 30 November 2013 and an increase of 11.71% over the previously announced net asset value of 36.37p at 10 October 2013, which was used as the basis for the Offer Price set out in the Prospectus for the Offer for Subscription issued by the Company on 24 October 2013. The rise in the net asset value over that period reflects the performance of AIM quoted securities in general and, in particular, certain investments in the Company's portfolio within the energy sector. As the Board recognises that the share prices of its AIM quoted investments in general, and these investments in particular, may remain volatile, the Directors intend to review the net asset value of the Company prior to the first allotment of shares under the Offer for Subscription, due to take place on or after 3 February 2014, and reserve their discretion to amend the Offer Price in accordance with the Prospectus. Any variation in the Offer Price will be announced through a regulatory information service.

 

In accordance with Listing Rule 15.5.1, and further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Section 118C of the Financial Services and Markets Act 2000) that the Directors and the Company may have in their possession relating to the Company during the period leading up to the announcement of its financial results for the year ended 30 November 2013 has previously been notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

27 January 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRSEAFMWFLSEIF
Date   Source Headline
21st Jul 20239:48 amRNSIssue of Equity
17th Jul 202310:57 amRNSNet Asset Value - Dividend Investment Scheme
11th Jul 20234:47 pmRNSNet Asset Value
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
14th Jun 202310:33 amRNSDividend Declaration
2nd Jun 20239:48 amRNSIssue of Equity
5th May 202310:23 amRNSIssue of Equity - Dividend Investment Scheme
27th Apr 20233:57 pmRNSTransaction in Own Shares
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202311:39 amRNSNet Asset Value - Dividend Investment Scheme
25th Apr 20233:14 pmRNSNet Asset Value(s)
25th Apr 202312:50 pmRNSResult of AGM
5th Apr 202312:32 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
23rd Mar 20235:18 pmRNSAnnual Financial Report
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:44 pmRNSTransaction in Own Shares
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 20239:48 amRNSIssue of Equity
1st Feb 20233:25 pmRNSUnaudited NAV and Proposed Final Dividend
9th Nov 20223:02 pmRNSResult of General Meeting
4th Nov 20223:25 pmRNSTransaction in Own Shares
26th Oct 20223:53 pmRNSTransaction in Own Shares
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
4th Oct 20221:35 pmRNSNet Asset Value(s)
26th Aug 202210:14 amRNSIssue of Equity
22nd Aug 20229:36 amRNSStatement re Dividend Investment Scheme
11th Aug 20224:47 pmRNSTransaction in Own Shares
25th Jul 20227:00 amRNSHalf-year Report
12th Jul 202212:40 pmRNSUnaudited Net Asset Value and Dividend Declaration
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
4th May 20229:28 amRNSIssue of Equity - Dividend Investment Scheme
3rd May 20225:07 pmRNSTransaction in Own Shares
28th Apr 20224:37 pmRNSStatement re Dividend Investment Scheme
27th Apr 202211:10 amRNSNet Asset Value(s)
26th Apr 20221:01 pmRNSResult of AGM
10th Mar 20224:57 pmRNSAnnual Financial Report
10th Mar 20227:00 amRNSRelated Party Transaction
23rd Feb 20223:57 pmRNSTransaction in Own Shares
17th Feb 20224:45 pmRNSTransaction in Own Shares
16th Feb 20223:56 pmRNSTransaction in Own Shares
9th Feb 20224:51 pmRNSTransaction in Own Shares
4th Feb 20224:26 pmRNSStatement re NAV and Dividend
26th Nov 202111:13 amRNSDirector/PDMR Shareholding
26th Nov 202111:11 amRNSDirector/PDMR Shareholding
26th Nov 202110:50 amRNSIssue of Equity
22nd Nov 202110:54 amRNSStatement re Dividend Investment Scheme
20th Oct 20211:00 pmRNSDividend Declaration
8th Oct 20214:03 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.